 |
Alaska Administrative Code (Last Updated: January 12, 2017) |
 |
Title 5. Commercial and Subsistence Fishing and Private Nonprofit Salmon Hatcheries. (5 AAC 1 - 5 AAC 41). |
|
Part 5.1. Commercial and Subsistence Fishing and Private Nonprofit Salmon Hatcheries. |
|
Chapter 5.41. Transportation, Possession, and Release of Live Fish; Aquatic Farming. |
|
Article 5.41.3. General Provisions. |
Section 5.41.080. Reporting and control of fish diseases at egg-take sites, hatcheries, and rearing facilities.
Latest version.
-
(a) The requirements of this section apply to all public and private egg-take programs, fish hatcheries, and fish rearing facilities in the state. (b) Within 24 hours of taking and fertilizing live fish eggs or transporting live fish eggs between watersheds, all eggs must be treated, for at least 10 minutes, with an iodine solution of at least 100 parts per million of active iodine ingredient, with pH at least 6.0 or greater, or in a manner approved by the fish pathology section of the department. This requirement does not apply to shellfish eggs, and the commissioner may also exempt eggs taken at large-scale pink and chum salmon facilities where the operational history for the preceding five years shows that disease has not been a problem in returning stocks of fish. (c) As determined by the commissioner, each fish hatchery or fish rearing facility may be inspected by the department's fish pathology section once every other year or less depending on the suitability of the fish stock disease histories. The commissioner may require and conduct additional inspections if the disease history of the stock or facility is incomplete, or if the disease history or current condition of the stock evidences incidence of disease. (d) The occurrence of any of the following pathogens or diseases of fish must immediately be reported to the department's fish pathology section: (1) Finfish Pathogen Categories: (A) Class I - Pathogens of Critical Concern. (i) Piscirickettsia; (ii) VHSV - Viral hemorrhagic septicemia virus (genotypes I - III and IVb); (iii) IPNV - infectious pancreatic necrosis virus; (iv) OMV - Oncorhynchus masou virus; (v) Herpesvirus salmonis; (vi) Whirling disease (Myxobolus cerebralis); (vii) ISAV - Infectious salmon anemia virus; (B) Class II - Endemic Pathogens of Concern: (i) IHNV - Infectious hematopoietic necrosis virus; (ii) VHSV - Viral hemorrhagic septicemia virus (type IVa); (iii) BKD - Bacterial kidney disease (Renibacterium salmoninarum); (iv) Furunculosis (Aeromonas salmonicida); (v) ERM - Enteric redmouth (Yersinia ruckeri); (vi) ICH - Ichthyophthiriasis (Ichthyophthirius multifiliis); (C) Class III - Nuisance Pathogens: (i) Vibriosis (marine Vibrio (Listonella) anguillarum, V. ordalii, V. alginolyticus); (ii) Cold water disease (Flavobacterium psychrophilum); (iii) Columnaris (Flavobacterium columnare); (iv) Trichodiniasis (Trichodina, etc.); (v) Ichthyobodiasis (Ichthyobodo = Costia); (vi) Hexamitiasis (Hexamita); (vii) Lymphocystis Virus; (viii) Helminth diseases; (ix) Fungal diseases (Saprolegnia sp.; Phoma herbarum); (x) Motile bacterial septicemias (Aeromonas hydrophila, Pseudomonas sp.); (D) Class IV - Uncategorized Pathogens: (i) VENV - Viral erythrocytic necrosis virus; (ii) PKD - Proliferative kidney disease (Tetracapsula bryosalmonae); (iii) Vibrio salmonicida (cold water marine Hitra); (iv) Loma sp. (Microsporidian); (v) Reovirus; (vi) Paramyxovirus; (vii) Aquabirnavirus; (viii) Erythrocytic Inclusion Body Syndrome (EIBS) virus; (ix) Ceratomyxa shasta (Myxosporidian); (2) Emerging Finfish Pathogens not defined in Classes I, II, III, or IV, including non-salmonid agents; (3) Shellfish Pathogen Categories: (A) Class I - Oyster Pathogens - Critical Concern: (i) European Hemocyte and Gill Iridoviruses (HIVD, GNVD); (ii) Oyster Herpesvirus; (iii) Ostracoblabe implexa (shell disease fungus); (iv) Haplosporidium sp. (nelsoni; costalis); (v) Perkinsus marinus, P. atlanticus and other similar protozoa; (vi) Marteilioides chungmuensis; (vii) Marteilia sp. (refringens, sydnei, branchialis, Aber disease, QX); (viii) Bonamia ostreare, Bonamia sp. (microcells); (ix) Velar disease virus (OVVD Iridovirus); (x) Mytilicola sp. (intestinalis, orientalis, parasitic copepods); (xi) Malpeque Bay disease (unknown etiology); (xii) Denman Island and Australian winter diseases (Mikrocytos mackini, M. roughleyi); (B) Class II - Nuisance Oyster Pathogens or Pests: (i) Pacific oyster nocardiosis (Nocardin crassostreae); (ii) Prokaryote inclusions (chlamydia; mycoplasma, rickettsia); (iii) Bacillary necrosis (Vibrio, Pseudomonas, Aeromonas, others); (iv) Sirolpidium zoophthorum (fungus); (v) Mycelial disease (Actinomycete-like); (vi) Hexamita sp. (flagellate protozoan); (vii) Ciliates (Sphenophrya, thigmotrichs, trichodinids, Ancistrocoma); (viii) Nematopsis sp. (sporozoan); (ix) Microsporidea (HEP and others); (x) Helminth parasites; (xi) Pseudomyicola sp. (parasitic copepod); (xii) Gregarines (protozoa); (xiii) Neoplasia (germinomas); (xiv) Ovacystis virus (gametogenic papilloma/polyoma-like virus); (xv) Symbionts: Polydora sp. (polychaete mudworm); Diplothyra sp. (boring clam); Cliona sp. (boring sponge); Bryozoa; (xvi) Predators: Stylochus sp. (polyclad worm); Drills: Urosalpinx cinerea; Ocenebra japonica; Rapana sp.; (C) Class III - Endemic Pathogens of Concern in Bivalves Other than Oysters: (i) Herpesviruses - littleneck clams, rock scallops; (ii) Histozoic coccidian - littleneck clams; (iii) Disseminated neoplasia - littleneck clams, blue mussels; (iv) Pseudoklossia coccidia - littleneck clams, basket cockles, blue mussels. (e) Diseases reported under (d) of this section, or found by inspection under (c) of this section, must be treated by taking steps acknowledged by the fish pathology section to be effective in eliminating the disease. Containers or facilities must be disinfected by the permittee in a manner directed or approved by the commissioner. (f) If the commissioner determines that a Class I disease pathogen in finfish stocks or Class I disease pathogen exotic to North America in shellfish stocks is detected within a hatchery or rearing facility, the commissioner will require immediate action, including quarantine, stoppage of water flows to eliminate effluent release, complete destruction and proper disposal, such as caustic lime burial or incineration, of affected stocks within the facility, and a thorough disinfection of holding areas and equipment. An affected facility may be required to remain dry or out of production for one year and be certified free of the disease pathogen before continued production of fish or shellfish. If Class I disease pathogens exotic to this state, but not to North America are detected in oysters in this state, destruction of those oysters by the permittee may be required if the commissioner determines that the disease pathogen poses a threat to the health and perpetuation of native, wild, or hatchery stocks of shellfish in the immediate area or the intended release location. In limited circumstances, the commissioner may allow retention or transportation of these diseased fish or shellfish under controlled conditions that pose no threat to native, wild, or hatchery stocks of fish and shellfish, such as movement to a disease laboratory having effluent depuration. (g) Stocks of finfish in hatcheries or rearing facilities in which a Class II disease pathogen has been detected may require destruction and complete disinfection of the facility by the permittee depending on the pathogen involved as determined by the commissioner, and if the disease poses a threat to the health and perpetuation of native, wild, or hatchery stocks of finfish in the hatchery effluent watershed or the intended release location. (h) The presence of pests recognized in Class II nuisance pathogens which may be exotic to this state will result in refusal of shellfish import certification by the commissioner until resubmitted representative samples of the shipment are free of nontarget invertebrate species. The commissioner will also refuse certification or restrict movement of oysters if there is oyster mortality or disease associated with the prevalence of any infectious pathogens.
Authorities
16.05.251